Hims & Hers to sell Lilly's Zepbound on its telehealth platform

Teladoc Health

01/04/2025 18:28

Refiles to correct day in paragraph 1 to Tuesday from Monday

April 1 (Reuters) - Telehealth firm Hims & Hers Health HIMS.N said on Tuesday it plans to sell Eli Lilly's LLY.N weight-loss drug Zepbound on its platform.

Shares of the company were up 8.5% in afternoon trading.

 (Reporting by Sneha S K in Bengaluru; Editing by Arun Koyyur)

 ((Sneha.SK@thomsonreuters.com;))